To review the current state of regenerative cell therapy for the intestine, kidney, liver, lung, and heart, emphasizing the significance of enhancing engraftment and discussing future directions.
Key Findings:
Regenerative therapies aim to restore or replace lost functional cells in degenerative diseases, with specific examples of successful applications.
Cell replacement therapies are still in early stages compared to successful CAR T-cell therapies, highlighting the need for further development.
Different organs have unique delivery routes and engraftment efficiencies for cell therapies, which should be detailed.
Machine perfusion of transplant organs can enhance the delivery and monitoring of regenerative cells, with examples of its application.
Interpretation:
The review highlights the potential of cell therapy in organ regeneration, emphasizing the need for improved delivery methods and engraftment strategies, and their implications for clinical practice.
Limitations:
The review focuses on specific organs and may not encompass all aspects of regenerative therapies, potentially introducing bias.
Exclusion of studies solely focused on extracellular vesicles or immune modulation may limit the scope.
Conclusion:
Cell therapy holds promise for organ regeneration, but further research is needed to optimize delivery and engraftment techniques, particularly in underexplored areas.
